- £14.86m
- £8.01m
- £5.72m
Annual income statement for Parkmead, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.08 | 3.61 | 12.1 | 14.8 | 5.72 |
| Cost of Revenue | |||||
| Gross Profit | 1.27 | 1.77 | 10.8 | 12.5 | 3.42 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.26 | 16.4 | 6.92 | 50 | 4.38 |
| Operating Profit | -0.177 | -12.8 | 5.21 | -35.2 | 1.34 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.792 | -13.4 | 3.96 | -35.3 | 1.07 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.482 | -13.8 | -0.814 | -40 | 3.43 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.482 | -13.8 | -0.814 | -42.3 | 4.94 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.482 | -13.8 | -0.814 | -42.3 | 4.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.001 | -0.06 | 0.011 | -0.093 | 0.028 |